Back to Agenda
Closing Plenary
Session Chair(s)
Tim Chesworth
Senior Director Regulatory Affairs
AstraZeneca, United Kingdom
Anja Wiersma, PhD
CEO and senior consultant
Mi-Ce Consultancy, Netherlands
Panel Discussion and Q&A
Speaker(s)
Combination Products: Building Blocks for Future Patient Care
Gert Bos, PhD, MSc
Qserve Group B.V., Netherlands
Chief Scientific Oficer, Executive Director, Partner
Combination Products: Towards Harmonised Interpretations
Sabina Hoekstra-van den Bosch, PharmD, MSc, RPh
Tüv Süd, Netherlands
Global Director Regulatory Strategy
Christelle Bouygues, PharmD
European Medicines Agency, Netherlands
Regulatory Affairs Senior Officer
Have an account?